ReviewNature clinical practice. Urology2009
Risk factors for prostate cancer.
Review in Nature clinical practice. Urology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
73 citing papers in PubMed, 4 syntheses or guidelines pooled it, 146 citations in OpenAlex.
- Correlation between serum triglycerides and prostate cancer risk in Chinese men: a meta-analysis.Frontiers in oncology · 2026Pooled it
- Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis.Journal of cancer research and clinical oncology · 2023Pooled it
- Association between periodontal disease and prostate cancer: a systematic review and meta-analysis.Medicina oral, patologia oral y cirugia bucal · 2021Pooled it
- Dietary antioxidants and prostate cancer: a review.Nutrition and cancer · 2013Pooled it
- Exploring Genetic Contributions to Prostate Cancer Risk in an Asian Population-Based Study.Cancer medicine · 2026Article
- β, β-Dimethylacrylshikonin Triggers Caspase-Mediated Cell Apoptosis via Heme Oxygenase-1 Upregulation and ERK/p38 Activation in Prostate Cancer.Journal of cellular and molecular medicine · 2026Article
- Development and Validation of a Genome-Wide Association Study Based Polygenic Risk Score for Prostate Cancer in an Asian Population.The world journal of men's health · 2026Article
- LncRNA expression in prostate cancer: FromNon-coding RNA research · 2026Article
- A Case-Control Study of Association Between Serum Levels of 19 Trace Elements with Prostate Cancer in Southwest China.Biological trace element research · 2025Article
- Human papillomavirus infection among men and its role in the etiology of prostate cancer: A prospective study.Central European journal of urology · 2025Article
- Investigating MRI-Associated Biological Aspects of Racial Disparities in Prostate Cancer for African American and White Men.Journal of magnetic resonance imaging : JMRI · 2025Article
- The relationship between the neutrophil percentage to albumin ratio and the occurrence of prostate cancer.PloS one · 2025Article
- Functional variants of the pentraxin 3 gene are associated with the metastasis and progression of prostate cancer.Journal of cellular and molecular medicine · 2024Article
- Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.Molecular carcinogenesis · 2024Article
- Lanthanide MOF-based luminescent sensor arrays for the detection of castration-resistant prostate cancer curing drugs and biomarkers.Chemical science · 2024Article
- Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort.PLoS computational biology · 2024Article
- Proteomics of prostate cancer serum and plasma using low and high throughput approaches.Clinical proteomics · 2024Article
- Radiotherapy Metastatic Prostate Cancer Cell Lines Treated with Gold Nanorods Modulate miRNA Signatures.International journal of molecular sciences · 2024Article
- Develop prediction model to help forecast advanced prostate cancer patients' prognosis after surgery using neural network.Frontiers in endocrinology · 2024Article
- Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR.Mini reviews in medicinal chemistry · 2024Review
13 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence of prostate cancer continues to increase in the US. Compared with other common cancers such as those of the breast and lung, the causes of prostate cancer remain poorly understood. Research endeavors continue to identify predictors of risk for prostate cancer, of which familial and genetic factors are among the strongest. Known risk factors can show significant heterogeneity in their association with prostate cancer development. However, the identification and further characterization of risk modifiers might provide insight into treatment and prevention of prostate cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.